Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Sales

1,002.97 805.60 813.56 831.81 728.29

Operating profit

165.13 86.17 135.47 120.69 71.30

Interest

0.63 0.95 1.09 1.14 -

Gross profit

190.59 99.99 147.22 132.54 87.59

EPS (Rs)

39.72 24.64 37.32 28.88 21.78
Annual  results in details
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Other income

26.10 14.76 12.84 12.99 16.29

Stock adjustment

-48.86 14.47 2.95 -39.21 -1.38

Raw material

84.38 89.61 97.26 70.21 62.67

Power and fuel

- - - - -

Employee expenses

259.10 230.21 219.54 216.70 197.40

Excise

- - - - -

Admin and selling expenses

- - 45.21 55.76 79.80

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

543.22 385.14 313.14 407.66 318.50

Provisions made

- - - - -

Depreciation

16.26 16.95 20.13 18.58 14.92

Taxation

34.81 21.44 33.79 41.75 18.22

Net profit / loss

99.29 61.59 93.30 72.21 54.44

Extra ordinary item

-40.23 - - - -

Prior year adjustments

- - - - -

Equity capital

5.00 5.00 5.00 5.00 5.00

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

16.46 10.70 16.65 14.51 9.79

GPM (%)

18.52 12.19 17.81 15.69 11.76

NPM (%)

9.65 7.51 11.29 8.55 7.31
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com